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ABSTRACT
DAVID A. COZZIE.  Characterization of the Mutagenicity
Formed During The Reaction Of Monochloramine And Fulvic
Acid.  (Under the Direction of Dr. LOUISE M. BALL)
Monochloramine has been recommended as an alternative
disinfectant to chlorine to aid in reducing production of
THMs.  This study sought to develop an effective protocol
for recovery of mutagenic by-products from chloramination of
fulvic acid solutions and then to characterize the mutagens
present.  Three methods of recovery were used: resin
adsorption, lyophilization, and liquid-liquid extraction.
Liquid-liquid extraction at low pH (pH=2) proved to be the
most effective method of recovery.  The total activity was
19% of that formed by chlorination of humic materials.  The
mutagens formed were direct-acting in nature and induced
base-pair substitutions.  Glutathione greatly reduced the
activity present.  BSA had a limited effect.  HPLC
fractionations to separate the compounds showed the most
mutagenic activity to be in the most polar fraction.
Efforts to determine the presence of the strong mutagen MX
showed MX could account for as much as one-third of the
total mutagenic activity formed by the reaction of
monochloramine and fulvic acid.
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I. INTRODUCTION
The major concern with drinking water has changed
over time.  Initially, availability of a clean water source
was a problem, then taste and odor for aesthetic reasons,
and then contamination by microorganisms that may induce
illness.  However, in the United States, these have been
overcome in the 20th century by the incorporation of a
disinfection process.  In most instances the disinfectant of
choice is chlorine.  Chlorine is a strong oxidant and
disinfectant and is stable enough to maintain a residual in
the distribution system.  But, in 1974, Rook reported that
chlorination reacts with natural organic compounds present
in surface waters to produce chloroform and other volatile
trihalomethanes.  The National Cancer Institute (1976) later
implicated chloroform as a human carcinogen.  Later research
(Christman et. al. 1983; Holmbom et. al., 1984; Kronberg et
al, 1985; Meier et. al., 1986) determined that many
nonvolatile organic halides, including 3-chloro-4-
(dichloromethyl)-5-hydroxy-2(5H) furanone (MX), were formed
as a direct result of chlorination and produced mutagenicity
in the Ames assay. Against this background, a more intense
search for alternative disinfectants was begun.
2Monochloramine (NHjCl) although a weaker oxidant and
disinfectant than chlorine, produces a more stable residual,
and produces less TOX than chlorine at comparable doses
(Fleischacker and Randtke, 1983).  NHjCl has been suggested
by the EPA (1983) as an effective method for reducing the
total organic halides formed, even though Symons et. al.
(1981) reported that the research on disinfection by¬
products of monochloramine was limited.
At a time when the regulatory posture is inclined
towards promulgating new laws restricting the presence of
total trihalomethanes and other organic halides in the
drinking water supply, it is advantageous to acquire a more
thorough understanding of the by-products of alternative
disinfectants such as monochloramine.  With this in mind,
this project was done with the following objectives:
I.  Determine a consistent, reproducible method of
recovering mutagens formed during the reaction of
monochloramine and fulvic acid.
II.  Characterize the Ames assay mutagens based on
their ability to induce mutagenicity in the
Salmonella strains TAIOO and TA98, and then by
the effect of exogenous metabolizing systems on
the mutagens.
III.  Fractionate the mutagens present by reverse phase
High Performance Liquid Chromatography (HPLC) in
an effort to separate the mutagens and then
3identify the principal active compounds based on
their mutagenic activities.
IV.  Establish the presence of the strong mutagen 3-
chloro-4-(dichloromethy1)-5-hydroxy-2(5H)
furanone and determine its contribution to the
overall mutagenicity of the chloraminated fulvic
acid.
II.  BACKGROUND
II. 1. :  Disinfection By-products in Drinking Water
Over the last two decades great emphasis has been
placed on the determination of volatile and non-volatile
contaminants formed by the treatment of drinking water with
standard (chlorine) and alternative disinfectants (including
the use of monochloramine).  The EPA (1983) has recommended
chloramination as an effective measure to control the THMs
produced during disinfection.  The research on by-products
formed in drinking water treated with chlorine is far more
extensive than on drinking water disinfected with
monochloramine.  However, many of the reaction products are
believed to be common to both and therefore some important
aspects of chlorination will also be discussed.
II. 1. (a) : Discovery in Chlorinated Drinking Water
The presence of organohalides in drinking waters
first came to light in the early 1970's when Rook (1974) and
Bellar ejt al (1974) reported the discovery of
trihalomethanes (THMs) in municipal water supplies. These
chemicals were volatile organics and were primarily bromo-
and chloro- substituted methanes.
5In 1977, the National Academy of Sciences reported
that 90% of the dissolved organic content in drinking waters
is comprised of relatively non-volatile organic compounds
which are extractable by organic solvents or resin
adsorption.  These non-volatile organics are believed to
account for a majority of the mutagenicity present in
extracts (Meier et al, 1983).  Polar, acidic molecules are
believed to account for as much as 90% of the total
mutagenic activity in these extracts, and nonpolar, neutral
compounds comprise the final 10%.  The acidic nature of the
mutagenic compounds was further confirmed by the increased
recovery of mutagens at low pH (Kronberg et al, 1985).
Meier (1988) was able to show that these by-products were
the direct result of chlorination.
Many investigators have undertaken the formidable
task of identifying the compounds formed during the
disinfection process (believed to be greater than 1200).
This research has resulted in the discovery of
chloroacetones, chlorophenols, hydroxyfuranones, and
chlorinated acids (Christman et al, 1983; Coleman et al.
1987; Hemming ^ al, 1986; Holmbom et al, 1984; Johnson gt
al. 1982; Kringstad et al, 1983; Meier et al, 1985; 1986,
1987b; Munch et al, 1987).
However, these compounds are present at levels too
low to account for the total mutagenic activity present in
the extracts from chlorinated waters.  The notion of
6synergistic activity among compounds formed during
disinfection has been widely disregarded (Hemming et al,
1986; Meier et al, 1986).  Fielding and Horth (1986)
demonstrated that fourteen identified compounds of known
activity accounted for less than 10% of the total activity.
Because of limited knowledge of disinfection by-products
(DBFs) and its potency as a bacterial mutagen, 3-chloro-4-
(dichloromethyl)-5-hydroxy-2 (5H) furanone, MX, has become
an important compound in the investigations of DBFs.
II. 1. (b) : MX in Drinking Water
MX was first discovered in Kraft chlorination
effluent (Holmbom et al, 1984).  It was later determined to
be present in drinking water extracts (Meier et al, 1986).
MX was designated as one of the most potent mutagens tested
in the Ames Salmonella assay.  It was the first single
mutagen identified that could account for a significant
fraction of the mutagenic activity in water extracts
(Kronberg et al, 1987; Meier et al, 1987b).  MX could
account for 5-60% of the total activity, with estimates
ranging from 5600 to 13000 net revertants/nmole (Hemmming et
al. 1986; Kronberg et al, 1987; Meier et al, 1987a,b;
Vartianen, 1989).
Certain structural features appear to be essential to
the mutagenic activity of MX. Ishiguro et ai (1988)
determined that a cis arrangement around the double bond
7greatly enhanced the mutagenic activity present.  They also
determined that the dichloromethyl group must be alpha to
the aldehyde group to enhance the electrophilicity of the
molecule and therefore the mutagenicity.  They finally
concluded that the same furanone structure with no chlorine
was non-mutagenic.
II. 1. (c) :  Formation of Mutagens During Chloramination
The need for research on chloramines has been
recognized since 1981, when Symons et al stated "Information
regarding the specific by-product formation from chloramines
under drinking water conditions is virtually absent from the
literature." Regardless, the EPA recommended chloramination
as an effective method of reducing THMs in 1983.
It has been postulated that monochloramine may be a
chlorinating agent itself or may liberate chlorine by
hydrolysis (Burtschell et al, 1959).  If this is in fact
true, then many of the compounds formed during chlorination
would also be formed during chloramination.
No rigorous experimentation has yet been done to
identify the by-products formed during chloramination nor
has any research centered on quantifying the presence of the
strong mutagen MX.  It is known that NHgCl reacts slowly
with phenols to form chlorophenols (Burtschell et al, 1959).
Backlund efe al (1988) attributed 24% of the mutagenic
activity formed during chloramination to MX.  They also
8found the total activity to be only 50% of chlorination and
the MX present to be only 25% of that formed during
chlorination.
It is known that monochloramine (NHjCl) produces
smaller amounts of THMs than chlorine (less than 3% of the
chloroform produced by chlorine at oxidant levels less than
20 mg/1) and only 9-49% of the non-purgeable total organic
halide (NPTOX) (Fleischacker and Randtke, 1983).  However,
this decrease in NPTOX may be due to the fact that the total
organic halide (TOX) produced by chloramine is larger in
molecular size and more hydrophilic making recovery more
difficult (Jensen et al, 1985).  Ultimately, NHjCl may be a
better disinfectant in regards to human health effects
because of its limited interaction with fulvic acid.
II. 2. :  Genotoxicity
The greatest concern regarding DBFs is that these
compounds may cause adverse human health effects.  Many
studies have shown that treated waters show increased
genotoxic activity over the untreated raw water source (Cheh
et al. 1980; Loper et ai, 1985; Nestman et al, 1979) and the
National Cancer Institute (1976) has implicated chloroform
as capable of inducing carcinomas in mice and renal tumors
in rats.
The most common method of estimating genotoxicity has
been the Ames Salmonella Assay.  This test procedure is
9favored because it is timely, relatively inexpensive, and
well documented.  All strains recommended for routine
testing (Ames et ai, 1975; Maron and Ames, 1983) have been
used with TAIOO and TA98 proving to be the most sensitive to
water extracts (Meier, 1988).  Activation by an exogenous
metabolizing enzyme is not needed and therefore the mutagens
are believed to be direct-acting frameshift or base-pair
substitution types.
II. 2. (a) : Genotoxicity of Drinking Water Extracts
Several investigators have noted a positive dose-
response relationship between concentrated drinking water
extracts and the revertants per plate in the Ames assay
(Backlund et ai, 1985; Kronberg et al, 1985; Loper et al,
1985; Meier et al, 1983).  In most of these assays, samples
were run simultaneously in the presence of S9, an exogenous
metabolizing enzyme,  resulting in a substantial decrease in
activity.  Tachibana et al (1989) also tested these
concentrates with various nucleophiles, such as glutathione,
and found these chemicals also significantly decreased the
mutagenic activity. This suggests that the compounds are
electrophilic in nature and can be deactivated by
nucleophilic compounds.  The presence of bovine serum
albumin (BSA), however produced no decrease in activity
(Meier efe al, 1983).  The ineffectiveness of BSA in reducing
10
the mutagenic activity suggests that the compounds present
do not undergo nonspecific protein binding.
Further testing has been done in eukaryotic cell
systems which are believed to be much more relevant to
mammalian cell systems.  Drinking water extracts were able
to transform BALB/3T3 cells in vitro (Lang et al, 1980).
Loper et ai (1978) also showed the ability of extracts to
transform BALB/3T3 cells in a dose related manner.  When
transplanted into Athymic nude mice, transformed cells were
able to induce tumor growth and reduce the latency period
until tumor growth (Kurzepa et al, 1984).
Other investigators have used a battery of assays,
including bacterial, eukaryotic and mammalian cell lines, to
compare effects.  Athanasiou and Kyrtopoulos (1983) showed
concentrated extracts were capable of causing mutations in
the Ames Assay, inducing sister chromatid exchanges (SCEs)in
mammalian cell lines and causing chromosomal aberrations in
Chinese hamster ovary (CHO) cells. Wilcox and Williamson
(1986) demonstrated that extracts were capable of inducing
chromosomal aberrations in CHO cells and human lymphocytes.
However, dosing mice by oral gavage showed no evidence of
clastogenic activity in bone marrow cells.  This suggested
inactivation of the mutagens prior to reaching the target
site in vivo.
Data from chronic toxicity studies is very limited.
Kool et ai (1985) undertook the task of evaluating the
11
carcinogenicity of drinking water concentrates.  After two
years of receiving extracts concentrated up to 68x the
normal water concentration, test mice showed no increased
levels of cancer, even though the extracts tested positive
in the Ames assay.  Bull et al (1982) also addressed this
problem with mixed results.  Samples shown to be mutagenic
in the Ames assay were not found to be significantly above
controls in their ability to initiate or promote tumors in
the SENCAR mouse skin initiation/promotion assay.
II. 2. (b) :  Genotoxicity of MX
, MX has been found to be a potent mutagen, accounting
for 15-57% of the mutagenic activity, and seems to be
deactivated in the presence of the exogenous metabolizing
enzyme system S9.  It has been proven to be more active at
low pH suggesting that the acidic closed ring form enhances
mutagenicity (Backlund et al, 1988; Holmbom et al, 1984;
Ishiguro §t  al, 1988; Meier et al, 1986; Vartiainen, 1989).
Other assays incorporated nucleophiles into the test plates
and found that nucleophiles, especially glutathione, greatly
reduced the mutagenic activity (Ishiguro et al, 1987;
Lampelo efe al, 1989; Meier et al, 1987).  Lampelo et al,
(1989) were also able to show that some nonspecific protein
binding occurred with BSA.
In a study to determine the ability of MX to form DNA
adducts, Meier et al (1989) found that MX forms adducts in a
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dose related manner in TAIOO bacterial cells, primary rat
hepatocytes, and rat liver embryonic cells.  In each case a
single major adduct was formed with a frequency of 1x10'^
per ug/ml. l.
The most extensive testing with MX was done by Meier
et al. (1987).  Using the Ames Salmonella assay with test
strains TA1535, TA1538, TA92, TA97, TA98, TAIOO, and TA102
in the absence of S9, they found a dose related response in
all strains with TAIOO being the most sensitive.  This
indicated that the MX was a direct-acting mutagen capable of
inducing frameshift or base-pair substitution type
mutations. MX was also able to induce chromosomal
aberrations in the CHO cell line.  The lethal dose 50 (LDjg)
by oral intake was determined to be 128 mg/kg/day.  However,
in vivo testing of MX failed to induce micronuclei in mouse
bone marrow even at the highest dose.  The inability of MX
to act in vivo is probably because it has a low rate of
bioaccumulation (Holmbom et al, 1984) and its electrophilic
nature makes it very reactive with nucleophiles such as
glutathione and diethyldithiocarbamate resulting in its
inactivation (Kopfler et al, 1988).
In vivo testing to determine the fate and
distribution of MX was conducted by Kopfler et al (1988).
After dosing the rats with 8 mg. of radiolabeled MX, they
found most of the dose was either excreted or respired.
Sacrifice after 48 hours revealed that only about 8%
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remained in the carcass and internal organs.  MX did produce
nuclear anomalies in the gastro-intestinal tract following
oral administration.  They, too, concluded that MX is
inactivated prior to reaching target cells.
II. 2. (c) :  Genotoxicity of By-products of Chloramination
Even though limited research has been done strictly
on the genotoxic effects of DBFs of monochloramine, some
studies have compared mutagenicity due to by-products formed
by monochloramine with by-products formed by chlorine.
It has been demonstrated that the mutagenic activity
of DBFs from monochloramination is far less than that of
chlorination by-products (Backlund et al, 1988; Cheh et al,
1980; Miller et al, 1986).  Backlund et al, (1988) reported
as much as a 50% decrease in the mutagenicity and more then
a 75% decrease in MX present when compared to chlorination
treatment.  Schenck et al (1990b) discovered the
mutagenicity to be two-fold less than that of chlorinated
waters and the by-products to be more active in the TA98
test strain.  Miller et al (1986) noted a decrease of
activity in the presence of S9.
Miller et aj, (1986) did the most extensive testing of
chloramination extracts.  They found that during in vivo
testing the sample extracts did not increase lung adenomas,
did not increase tumors in the SENCAR mouse initiation/
promotion assay nor were the extracts positive for the rat
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liver foci assay which determines the ability of the test
compound to initiate g-glutamyltranspeptidase (GGT)-positive
foci.  Finally, chloramine extracts did not alter organ
weights during in vivo toxicity testing.
In other in vivo testing, Fujie and Aoki (1988)
showed that chloramine extracts were able to induce
chromosomal aberrations in rat bone marrow cells in a dose
related manner.  Chloramine samples behaved most like
chlorinated extracts.  Bull et al (1982) found in skin
initiating/promotion studies that chloramine treated waters
increased the level of lung adenomas and doubled the
incidence of tumors as compared to controls.  Unfortunately
samples were not large enough to establish statistical
significance and these were only trends in the data.
From a literature standpoint, it is obvious that
limited work has been done on the identification of DBFs and
health effects of monochloramine. More research is needed
in both of these areas prior to widespread use of NHjCl in
the disinfection process.
II. 3. : Analytical Techniques
II. 3. (a) :  Concentration and Extraction of Organics
Organic compounds are present in drinking waters at
concentrations of 1 ug/liter or less.  Loper (1980) pointed
out that these levels in unconcentrated drinking waters were
not amenable to the Ames assay.  A more concentrated sample
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was necessary.  In recovering compounds of unknown
structures and physico-chemical properties it is necessary
to choose a method that (a) gives high recoveries of a wide
range of compounds, (b) uses a solvent that is compatible
with the intended bioassay and analytical method, and (c) is
able to process a large quantity of water in a reasonable
time (Kronberg, 1987).
Some of the methods in use include lyophilization,
reverse osmosis, solvent extraction and binding to various
adsorbents.  The most popular method of extraction is
macroreticular XAD resins (Kronberg, 1987; Meier, 1988).
Amberlite XAD-2, XAD-4, XAD-7, and XAD-8 are all non-ionic
resins.  XAD-2 and XAD-4 tend to extract non-polar compounds
and XAD-7 and XAD-8 preferentially extract compounds of
intermediate polarity. For this reason the favored column is
an equal weight mixture of XAD-8 and XAD-4 (van Rossum and
Webb, 1978).  The resins are eluted with an organic solvent
after concentration to obtain the extract.  The compounds to
be recovered and the selectivity of resins should be
considered when choosing a concentration and extraction
method.  Leenheer (1981) noted that one resin is incapable
of isolating any specific compound from the diverse organic
mixture.  Schenck et ai (1990a) reinforced the notion of
selectivity in resins with the discovery that MX was
recovered three-fold greater on XAD-8 than on XAD-2.
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Solvent extraction with diethyl ether is also
considered an effective method of extraction but the pH of
the water seems to be critical in governing the efficiency
of the process (Kronberg, 1987).  The increased recovery of
mutagenicity at low pH suggests that acidic compounds are
the major mutagens present in drinking water.  The
possibility of acidic, polar compounds being responsible for
the mutagenicity should also be considered in choosing
solvents for eluting the extract.  A polar solvent, such as
diethyl ether, should give greater recoveries than a non-
polar solvent, such as hexane.
Reverse osmosis was found to be a poor method of
recovery for the disinfection by-products of monochloramine
(Miller et ai, 1986).  Lyophilization, although resulting in
the loss of the volatile organics, is an effective method of
recovering the mutagenic activity associated with the non¬
volatile organics (Meier et al, 1983).
The theory of acidic compounds being primarily
responsible for the noted mutagenesis has been strengthened
by studies looking at the effect of pH on recovery of
mutagenicity (Holmbom et al, 1984; Kronberg, 1987; Meier et
al. 1986) and by the discovery of the acidic, strong mutagen
MX.
ZI. 3. (b) :  Bioassay Directed HPLC Fractionation
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Because of the vast range of compounds present in
drinking water extracts, it is advantageous to reduce the
organic mixture to as few compounds as possible while
retaining the most mutagenic activity.  One effective method
of doing this is the use of high performance liquid
chromatography (HPLC).  Crathorne (1979) demonstrated that
HPLC fractionation was ideally suited for the separation of
non-volatile matter in drinking water.  In an ideal
fractionation procedure, one final fraction containing a
single compound of high mutagenic activity would be isolated
for identification.  However, since this is rare, HPLC
fractionation allows for the separation of mutagenic samples
from non-mutagenic compounds which can then be examined by
mass spectrometry (MS).
The general procedure for fractionation is as
follows:  sorption/desorption on XAD resins followed by
liquid-liquid partitioning followed by repeated TLC or HPLC
fractionations.  Mutagenic compounds such as 3-(2-
chloroethoxy)-l,2-dichloropropene, MX, and E-MX have been
discovered by this method (Holmbom et al, 1984; Kronberg et
al 1987; Tabor and Loper, 1980).
II. 3. (c) : The Ames salmonella Assay
The underlying theory behind the Ames Salmonella
assay is that the process leading to the development of
cancer is initiated by mutations to somatic cells.  The Ames
18
assay Is an indicator of genetic damage within a bacterial
cell line.
The validity of the Ames assay is debatable.  Upon
initial review it was determined to be a very sensitive test
with specificity near 90% for detecting carcinogens (McCann
and Ames, 1976).  Recently, Tennant et al (1987) evaluated
several short-term assays for their ability to predict the
carcinogenicity of selected chemicals in rodents. The Ames
assay had a positive predictive value of only 62% which was
neither exceeded by any of the others nor was it improved
upon by a battery of assays.  A further indication of the
relationship between the Ames assay and carcinogenicity is
that known carcinogens that were positive in the Ames assay
tended to be more potent as carcinogens than those known
carcinogens that are not mutagenic (Rosencranz and Ennerer,
1990).
Bull et al (1982) suggested that appropriate
bioassays be used to screen water samples for genotoxic
activity.  To this point, the Ames assay has been the
primary method of screening water extracts (Kool et al 1985;
Leper, 1980; Meier, 1988; Meier et al, 1985).  However other
research has shown that genotoxic activity can be observed
in mammalian cell lines (Lang et al, 1980; Loper et al,
1978; Meier, 1988; Wilcox and Williamson, 1986). The
continued use of the Ames assay is a consequence of its
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ability to detect a wide range of mutagens in a time
effective and economical manner.
The Ames assay employs strains of Salmonella
typhimurium which contain well characterized mutations
within the genome.  The mutations occur in a group of genes
which code for the synthesis of the essential amino acid
histidine.  Specifically, these genes are hisG46 in TAIOO
and hisD3052 in TA98.  The assay measures the rate of back-
mutation to the normal wild-type cell.  The mutated tester
strains are unable to grow on histidine deficient culture
media.  However, after reversion occurs in the cell, the
normal gene function is restored and the cell is able to
grow on the histidine deficient media.  Some spontaneous
back-mutation will occur at a low rate but the addition of a
mutagenic agent will increase the level of reversion well
above the spontaneous rate (Ames et al, 1975; Maron and
Ames, 1983).  The relevance to mammalian cell lines is
enhanced by the incorporation of an exogenous metabolizing
system, 59, that includes the enzymes present in mammalian
cells but absent in the bacterial cell.  The addition of
this system aids in the detection of metabolically activated
(or indirect-acting) mutagens. The linear slope of the
dose-response curve can then be used to calculate the
mutagenic potency of the sample.
At the present there are several strains available
for routine screening including TA1535, TA1538, TA97, TA98,
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TAIOO, and TA102.  Loper (1980) recommended the use of TA98
and TAIOO for routine testing of water extracts because of
their proven sensitivity.  TA98 detects agents causing
frameshift mutations whereas TAIOO preferentially detects
agents causing base-pair substitutions at the G-C pairs.  It
is now suggested that TA102 also be used for screening
because some mutagens act specifically at the A-T base-pair
site (Levin et al, 1982).  TA102 detects base-pair
substitutions at the A-T site and is also able to detect
oxidative damage to the genome.
Ill: METHODS AND MATERIALS
III. 1. :  Materials
Salmonella typhimurium strains TA98 and TAIOO were
obtained from Dr. Bruce Ames, University of California at
Berkeley.  Sodium azide and 2-nitrofluorene were purchased
from Aldrich (Milwaukee, WI), 2-anthramine from Sigma
Chemical Co. (St. Louis, MO).  Oxoid Nutrient Broth #2 was
obtained from Oxoid Ltd. (Basingstoke, Hants, England).
Bacto-agar from Difco Laboratories was used initially but
due to production problems, several alternative agars were
tested and agar-agar from United States Biochemical
Corporation (Cleveland, OH) was selected as the most
suitable replacement.  Chemicals for the VBME salts were
acquired from Fisher Scientific (Fair Lawn, NJ).  Dextrose
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was purchased from Mallinckrodt Inc. (Paris, KY).  NADP and
glucose-6-phosphate were procured from Boehringer Mannheim
(West Germany).  Molecular Biology grade DMSO was obtained
from Fisher Biotech (Fair Lawn, NJ) as were L-histidine and
biotin.  S9 from the livers of Aroclor-1254 treated male
Sprague-Dawley rats was purchased from Moltox Inc. (College
Park, MD) .   Bovine seirum albumin (BSA) and glutathione were
bought from Sigma Chemical Co. (St. Louis, MO).  Crystal
violet was purchased from Aldrich/Milwaukee, WI).
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HPLC grade acetonitrile was obtained from Fisher
Scientific (Fair Lawn, NJ), diethyl ether from Burdick and
Jackson (Muskegon, MI).  Sodium hypochlorite phosphoric
acid, and sodium hydrogen phosphate were purchased from
Fisher Scientific (Fair Lawn, NJ).  Ferrous ammonium sulfate
was purchased from Allied Chemicals (Morristown, NJ).  XAD
resins were purchased from Rohm and Haas (Philadelphia, PA).
MX was donated by Dr. Paul Ringhand, USEPA Health
Effects Research Laboratories (Cincinnati, OH).
III. 2. :  Preparation of NH^Cl
In order to chloraminate the fulvic acid samples, it
was first necessary to prepare monochloramine in high
yields.  Initial efforts used ammonia and chlorine in a 3:1
mole ratio, pH 7.0 in 0.005M phosphate buffer, at room
temperature.  Equal liquid volumes of ammonia and chlorine
were then added with vigorous stirring in an attempt to
produce 5 millimolar(mM) monochloramine.  This protocol
produced only 1.6 mM NHjCl for a 38% yield as determined by
amperometric titration using a MPI (Dannville, CA)
amperometric titrator with a Calomel electrode and Linear
(Irvine, CA) recorder.  For subsequent NHjCl preparations
the DPD Ferrous Titrimetric Method (Std. Methods, 408D,
1989) was used to determine the concentration of
monochloramine made.
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A second reaction procedure provided a high yield of
monochloramine:  4.80 mM monochloramine from 5.0 mM
chlorine.  The 96% yield was produced by reacting the equal
volume mixtures at pH 8.0 and at ice bath temperature.
After being allowed to stand for three days at room
temperature the concentration of monochloramine had
decreased to 2.2 mM.  This indicated that NHjCl had to be
made fresh with each experiment in order to insure no
degradation of NH2CI had occurred.  This work was carried
out in collaboration with R. Kanniganti (1990).
III. 3. :  Fulvic Acid
Fulvic acid (FA) was chosen as the model organic
organic compound for the study.  Fulvic acid is hydrophilic
in nature, has the lowest molecular weight of the fractions
composing natural organic material, and accounts for the
highest concentration of dissolved organic carbon in surface
waters (Thurman and Malcolm, 1981).  The FA from Lake
Drummond has been characterized as a low ash content and a
carbon content of 48.81% (Jensen, 1983).
The fulvic acid in this study had previously been
isolated in the laboratory from Lake Drummond, VA by the
extraction procedure described by Thurman and Malcolm
(1981).  Briefly, this involves filtration of the lake
water, acidification, and adsorption on a XAD-8 resin, a
semi-polar macroporous methylmethacrylate polymer.  The
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humic and fulvic acids are then eluted in base and
neutralized.  The humic acid forms a precipitate and the FA
remains in solution.  The humics are then separated by
filtration.  The fulvic acid fraction is further treated by
readsorption onto the XAD-8 resin and reelution with base.
The sodium ions are removed by passing the extract through a
cation exchange column.
III. 4. Preparation of Seunple
The concentration (mM of Clj) of the freshly prepared
monochloramine was determined by amperometric titration or
by the DPD Ferrous Titrimetric Method (Std. Methods, 408D,
1989). FA (mM as C) was then added to achieve the desired
mole ratio. The total volume was one liter. The reaction
was carried out with constant stirring. The reaction
conditions for the initial experiments were as follows:
ClgiC molar ratio :  From 8.8:1 to 1:40
96 hours
8.0
Room Temperature
Reaction time
pH
Temperature
After 96 hours, the samples were tested amperometrically or
by the DPD Ferrous Titrimetric Method for residual
monochloramine.  After the reaction period the reaction
mixture was divided into two parts, the first was acidified
with HCl to pH 2.0, the second was maintained at pH 8.0 for
initial experiments.  These were then divided in half to
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produce four 250ml aliquots which were now ready for by¬
product recovery.  For later experiments, the total reaction
sample was acidified to pH 2.0 with HCl.  This work was
carried out in Collaboration with R. Kanniganti (1990).
III. 5. :  Recovery of Disinfection By-products
III. 5. (a) :  Resin Adsorption
The first step in the resin adsorption process was
cleaning the XAD resins.  First, the resin was batch
extracted several times with methanol and then sequentially
soxhlet extracted with methanol and ether.  Afterwards the
resins were packed in a 3 6 by 2.54cm column and eluted with
several bed volumes of distilled, deionized water.  Each
resin was subjected to two such cycles and then 150 ml of
resin were repacked into the column and thoroughly rinsed
with distilled deionized water.  The column was now ready
for sample extraction.
After the 96 hour reaction period, the sample was
divided into two parts. The first was maintained at pH 8.0;
the second was acidified to pH 2.0 with HCl.  The samples
were then passed through a XAD-8 column at the rate of one
bed volume per hour (one bed volume was determined to be 25
ml).  The resin was then soxhlet extracted with 250ml of
ether for 24 hours.  The ether extract was then concentrated
and stored in a -20°C freezer to await mutagenicity testing.
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XAD-4, a hydrophobic styrene divinyl benzene polymer,
was also used to extract the sample.  After passing the
sample through the XAD-8 resin, the eluate was acidified to
pH 1.0 with HCl and run on the XAD-4 resin.  The resin then
underwent the same procedure as the XAD-8 resin and the
extract was collected and stored for mutagenicity testing.
In the initial resin extractions, the residual
monochloramine was not eliminated prior to collection of the
by-products resulting in toxicity to the bacterial cells in
the Ames assay.  To remedy this inconvenience, ferrous
ammonium sulfate was used to quench the residual after
extraction.  Although positive results were achieved, there
was uncertainty surrounding the effect of the precipitate on
mutagenicity.  The mole ratios in the reactions would now be
limited by the monochloramine demand.
The demand level of the monochloramine was determined
by allowing various mole ratios to react for extended
periods of time (Table 1, Fig 1).  It was determined that
ratios with large quantities of FA would be needed for the
monochloramine to be completely reacted.
This work was done in collaboration with R.
Kanniganti (1990).
III. 5. (b) :  Lyophilization of samples
Reaction samples were prepared as described in
Chapter III. 4, however after the 96 hour reaction period
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the samples were divided into two parts.  The first was
allowed to remain at pH 8.0, the second was acidified to pH
2.0 with HCl.  These samples were then lyophilized on a
Labconco freeze- drier.  After freeze-drying the samples
were stored at -2 0°C in a solid state.  This portion of the
work was carried out by R. Kanniganti (1990).
III. 5. (c) :  Liquid-Liquid Extractions
Reaction samples were prepared as described in
Chapter III. 4..  After 96 hours the samples were acidified
to pH 2.0 with HCl, divided into three parts, and then
underwent three successive extractions with 40ml, 20ml, and
20ml of diethyl ether.  This method proved most effective
in removing the residual monochloramine, even at mole ratios
above the monochloramine demand levels.  The diethyl ether
extracts were concentrated to approximately 4 0ml under a
stream of Nj gas and then stored -20°C.  This work was
carried out in collaboration with R. Kanniganti (1990).
III. 6.  : HPLC Fractionation
Separations were carried out on a Varian 5000 HPLC
(Palo Alto, CA) equipped with a Whatman (Maidstone, England)
C,g Partisil-10 6x250mm ODS analytical column, a Whatman 6mm
ODS guard column, and a Rheodyne (Cotati, CA) injection
port.  HPLC effluent was monitored at 254nm using a Waters
(Milford, MA) Model 440 Spectrophometric detector and
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recorded on a Shimadzu Chromatopac CR2-AX integrator (Kyoto,
Japan).
Extracts of the 250ml reaction aliquots were prepared
for HPLC analysis by drying under Nj and redissolving in
0.5ml of acetonitrile (ACN) followed by addition of 0.7ml of
HjO.  This was the smallest volume and ratio that would
completely dissolve the sample present.  500ul of sample was
injected via a 500ul loop.  Solvents used for elution were
ACN and IxlO'^M phosphate buffer at pH 3.0.  Three fractions
were collected manually in Erlenmeyer flasks based on the
following separation scheme:
C,g analytical column. Flow Iml/min
Elution with ACN and Phosphate buffer (pH=3.0)
0-110 mm
110-150 min
150-190 min
90% buffer     10% ACN
50% buffer      50% ACN
100% ACN
The fractions were then transferred to a round bottom flask
and taken to dryness by rotary evaporation on a Buchi
Rotavapor R-110 (Switzerland) in a waterbath at SO^C.  The
fraction samples were then recovered by extraction of the
round bottom flask with 20ml of diethyl ether.  The
fractions were then stored at -20°C for mutagenicity
testing. This work was done in collaboration with R.
Kanniganti (1990).
III. 7.  : TOC Analysis
Total organic carbon analysis (TOC) was done in
accordance with the Persulfate-Ultraviolet Oxidation Method
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with infrared analysis (Std. Methods, 5310C) on a Model 700
TOC Analyzer from 0-I-Corporation (College Station, TX).
This work was donated by R. Kanniganti.  For a more detailed
discussion see R. Kanniganti (1990).
III. 8.  :  TOX Analysis
Total organic halide (TOX) analysis was done in
accordance with the Adsorption-Pyrolysis-Titrimetric Method
(Std. Methods, 5320B) on a Dohrmann Xertex TOX analyzer.
This work was done concurrently by R. Kanniganti.  For a
more detailed analysis see R. Kanniganti (1990).
III. 9.  : 6C/MS Analysis and MX Quantification
The material presented in this paper dealing with
GC/MS analysis and MX quantification was contributed by R.
Kannighanti, who was involved in concurrent work in this
area.  For a more detailed discussion of this material see
R. Kannighanti (1990).
III. 10.  : Mutagenicity (Ames) Assay
The test samples were stored in ether at -20''C.  At
the time of assay the samples were dried under a stream of
nitrogen gas and then redissolved in 2ml of DMSO.  All
assays for the whole reaction mix were done with a minimum
of four doses, 50ul, 75ul, lOOul, and 150ul, corresponding
to 25ml, 37.5ml, SOml, and 75ml of the 1 liter reaction mix
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respectively, each dose in duplicate.  Each experiment was
repeated on a separate day.  A linear dose response curve
with revertants on any dose plate greater than 2x background
was considered an indication of mutagenic activity.  The
mutagenic potency was determined from the slope of the line
fitted by linear regression on the data points.  For a
result to be accepted the correlation factor, r, had to
exceed 0.95.
The bacterial mutagenicity of the disinfection by¬
products of monochloramine was tested in strains TAIOO and
TA98 in accordance with the standard plate incorporation
assay described by Maron and Ames (1983).  Slight
modifications were introduced due to the use of U.S.
Biochemical agar-agar.  This agar tended to increase the
background rate of TAIOO, so only 12 gms/L of agar and 7
ml/L of histidine-biotin solution were used in the
preparation of plates used in TAIOO assays.  This returned
the spontaneous levels to within the acceptable historical
range.  The agar did not effect the spontaneous rate of the
TA98 strain, so the recipe was not changed.  The genotypes
of the two strains were as follows:
TAIOO :  his G46, for histidine dependence
rfa, crystal violet sensitivity
uvrB, damage to uv repair system
pKMlOl, ampicillin resistance
TA98  :  his D3052, histidine dependence
rfa, crystal violet sensitivity
uvrB, damage to uv repair system
pKM 101, ampicillin resistance
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The strains were stored in DMSO and nutrient broth at
-70°C.  Masterplates were prepared from frozen permanents
and stored at 4°C.  Verification of the masterplates for the
presence of genetic markers as well as spontaneous and
positive control rates was accomplished prior to use for
assay purposes.  Spontaneous and positive control plates
were included in duplicate with every experiment.  The
positive control and dose for each strain are as follows:
TAIOO (-S9)
TAIOO (+S9)
TA98  (-S9)
1.5ug Sodium Azide
0.5ug 2-Anthramine
3.Oug 2-Nitrofluorene
The effect of an exogenous xenobiotic metabolizing
enzymes on the sample was tested using Aroclor-1254 induced
rat liver homogenate fraction, S9.  The S9 solution was
composed of NADPH-generating cofactors (NADP and G-6-
Phosphate from Boehringer Mannheim (West Germany)), MgCl-KCl
salt solution (salts from Fisher Scientific (Fair Lawn, NJ),
and the rat liver homogenate dissolved in pH 7.5 phosphate
buffer. Nonspecific protein binding was assayed using Bovine
serum albumin (BSA).  The effect of a strong nucleophilic
compound was tested with glutathione.  The other proteins
used in this assay were dissolved in the same solution as
the S9.  Each protein was added to the top agar tube at a
dose of 0.80 mg protein in 500ul of solution.
In testing the HPLC fractions, only TAIOO (-S9) was
used because this proved to be the most sensitive strain to
the mutagens present.  Due to considerations for the
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division of mutagenic activity during separation and the
loss of material on the column, aliquots were taken up in
only 400ul of DMSO and only two doses, 50ul and lOOul, in
replicate were done.  This enabled the fractions to be
concentrated enough to exceed 2x background.  The same
criteria and methods of determining mutagenic activity were
used.
FIG 1:   MONOCHLORAMINE RESIDUAL AS A
FUNCTION OF TIME
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TABLE 1.   MONOCHLORAMINE RESIDUALS AT VARIOUS
01:C RATIOS
C1:C RESIDUAL CONCENTRATION (mM)
RATIO
Reaction Time (hrs)
48 96        142
1:2 10.03 0.97 0.49 0.31
1:5 4.01 0.79 0.51 0.31
1:20 1.00 0.11 0.06 0.03
1:40 0.50 0.01         ND ND
NO = Not done
Residual was measured by DPD Titrimetric method.
IV.  RESULTS
IV. 1.:  Recovery of Mutagenic By-products
IV. 1. (a) :  By-product Recovery Techniques
The first method used to recover and concentrate the
mutagenic activity of the reaction sample was adsorption
onto XAD resins.  Table 2 that at neutral pH (pH 8.0) there
was limited activity and at lower pH (pH 2.0) there was an
increase in mutagenic activity.  In comparing the results
from the different resins, XAD-8 was more effective in
recovery of mutagenic activity than the XAD-4 resin.  These
results suggest that the mutagenic compounds of the
monochloramine and fulvic acid reaction are polar and acidic
in nature.  One major problem in the interpretation of the
resin extract results was the mutagenic activity noted in
two of the blank samples.  This indicated the presence of
mutagenic artifacts on the columns.
The second method of recovery attempted was the
lyophilization of samples. No recovery of mutagenic
activity was seen at either pH. This may have been due to
product loss by volatilization (Results not shown).
The final method used for the extraction of by¬
products was liquid-liquid extraction.  This method was more
effective at mutagenicity recovery than the other methods
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(Table 3).  Molar ratios above the monochloramine demand
levels could be employed using this mean of extraction
because the residual monochloramine remains in the aqueous
layer and thereby eliminating any toxicity due to NHjCl
iself or artifacts in the blanks resulting from the reaction
of monochloramine.
Liquid-liquid extractions were simpler, less time-
consuming, provided increased recovery of mutagenic by¬
products, and did not produce mutagenic artifacts.
Therefore, for our purposes, liquid-liquid extraction was
the most effective method for mutagen recovery.
IV. 1. (b) : Reproducibility of Procedures
The first step was to determine the reproducibility
of mutagen production within and among reaction experiments.
The same reaction mix was assayed for mutagenicity on
separate days to demonstrate the consistency within a
reaction mix and within the assay procedure (Fig. 2).
However, Fig. 3 shows there can be a wide range of
variability in activity between experiments with the same
molar ratio and NHjCL and FA doses if done in separate
reaction vessels.  The variance found in these experiments
can be attributed to the reaction system (about 15% of the
total variance) and the mutagenicity assay (about 20% of the
total variance).
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IV. 1. (c) :  Relationship of NH^Cl Dose and Mutagenicity
Though the correlation of the second order regression
between the monochloramine dose and the total revertants is
only 0.74 (Fig. 4), this figure does suggest a biphasic
response to the NHjCl dose.  This indicates a plateau of
maximum mutagenic activity at higher monochloramine doses.
The second order regression is better reflected in Fig. 5, a
comparison of total revertants vs. the molar dose ratio.
This figure also suggests a strong correlation between the
molar ratio and the mutagenic activity, indicating
mutagenicity is a function of the monochloramine dose.
IV. 2.:  Recovery of TOC and TOX
An inverse relationship between recovery of total
organic carbon (TOC) and NHjCl dose is very evident in Table
4. The decrease in TOC is most likely a product of the
oxidative properties of the monochloramine resulting in the
formation of carbonate.
Unlike the TOC recovery from the reaction mix, the
TOC recovery in the extracts seems totally dose independent.
The extracts all recover in the range of 10.35 + 0.93% of
the TOC left after the reaction procedure.
From Table 5, it was noticed that the recovery of
total organic halide (TOX) increases with increasing NH2C1
dose.  An important aspect derived from this table is that
the total mutagenic activity is a function of the TOX
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recovered. At TOX values greater than l.o mg/L as C1-, the
response value in revertants/L plateaus.  Fig. 6, plotting
the % Clj incorporation (an indication of the total organic
halide formed) as a function of chlorine dose, suggests that
the TOX formation is limited at NH2C1 doses greater than
200mg/L of Clj.  However, caution must be taken in
interpreting this data because the TOX analysis is only one
replicate.
IV. 3.:  Strain Characterization
Another important aspect of mutagens is their
sensitivity to the various Ames tester strains.  TAIOO and
TA98 were the two strains used in this study because they
are indicators of two major mutagen types:  base-pair
substitutions and frameshift mutations.  Historically, TAIOO
has been more sensitive to DBFs.  Maximum activity was found
in TAIOO (Fig. 7, Table 6), indicating that the mutagens
caused base-pair substitutions. The results did exhibit
some peculiarities.  As evidenced in trials 21 & 22, the
blanks were active in TA98 but not in TAIOO.  This suggested
that TA98 was sensitive to one of the solvents or there was
contamination.  Research in this area proved inconclusive as
to the exact cause of contamination.  Another interesting
result found in trials 18b & 19b, was that TA98, while not
exhibiting as much mutagenic activity as TAIOO, displayed
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signs of toxicity at the higher dose levels whereas TAIOO
did not.
IV. 4.:  Effect of Exogenous Activation Systems
An important aspect of any mutagen is the effect an
exogenous activation system has.  Fig. 8 and Table 7 show
there is a significant decrease (p< 0.05) of 34,6 + 16.5%
due to the addition of S9, an exogenous metabolizing system
containing cytochrome P450.  This inactivation indicates the
mutagens present are most likely direct-acting in nature.
The addition of other systems also had a deactivation
effect on the present mutagens (Figs. 9, Table 8).  All
showed significant decreases in the total mutagenic
activity.  The decrease due to the presence of BSA suggests
that some of the mutagens (probably less polar molecules)
undergo nonspecific protein binding.  The large decrease due
to glutathione, 62.8 + 12.2 %, suggests an electrophilic
nature of the mutagens that is inactivated by binding with
this strong nucleophile.
IV. 5.: Mutagenic Activity of HPLC Fractions
The initial consideration in collecting fractions was
the ability to recover the injected mutagens (Fig 10).
Experimentation showed the use of a IxlO'^M phosphate buffer
at pH=3.0 tended to increase the recovery in the separation
process (Table 9).  To insure the increase in recovered
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activity was not an artifact of the buffer, reaction
products dissolved in the same phosphate buffer were assayed
(Results not shown).  These assays showed no increased
activity as compared to their non-buffered counterparts
indicating that the buffer increased recovery not activity.
The buffered separations consistently gave mutagenic
recoveries in the 50-60% range (Table 9,10) with Fl
containing the greatest portion of the mutagenic material.
This suggested that the most active compounds were acidic
and hydrophilic in nature.  The lack of activity in F3
reinforced the notion that the most active compounds were
polar, acidic and hydrophilic in nature.
After ascertaining the recovery of the mutagens
during fractionation, it was necessary to examine the
additive properties of the fractions to ensure no
synergistic or antagonistic effects were in effect (Fig 11,
Table 10).  It is clearly evident that regardless of the
collection procedure the recovery was maintained in the 50-
60% region.
Analysis of the TOC and TOX (Table 11) showed 83.3%
and 78.6% respectively to be collected in the first two
fractions.  This indicated that the recovery of TOX and TOC
was marginally better than the recovery of mutagenic
activity.  The large recovery in the first two fractions was
expected because past research has shown that recoverable
TOX coincides with the mutagenic activity.  Surprisingly
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though, the largest percentage of the TOC and TOX was
recovered in the second fraction which contained only a
third of the mutagenic activity, suggesting more potent
mutagens in Fl.
IV. 6. ;  Identification of Mutagenic Compounds
An important aspect of any disinfection by-product
study is the characterization of the mutagens formed in
order to possibly identify the compounds present.  The work
to this point suggested that the sample had great
similarities to the strong mutagen MX and therefore it was
decided to further pursue the identification of MX in the
by-products of chloramination.
Initial work in the determination of MX included the
use of proteins to compare the percent decrease in the
mutagenic activity of MX with the previously discovered
decrease in activity of the chloramine by-products (Fig. 12,
Table 12).  The decrease in activity of the pure MX showed a
significant difference over the decrease in the chloramine
activity at the p<0.05 level for S9, BSA, and glutathione.
This hinted that MX may contribute to the overall
mutagenicity of the sample, but there were other mutagens
present that contributed significantly (possibly upto 70%)
to the overall activity of the sample
Fractionation of the pure MX under the same
separation regimen showed all of the recovered activity to
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elute in the first fraction (Fig 13, Table 13).  since MX is
a strong bacterial mutagen, this could explain why Fl,
though containing a lower TOX concentration, has a greater
percentage of the mutagenicity.  A final fractionation
procedure in which Sing of unreacted fulvic acid and 250ng of
MX were co-injected to determine if the presence of FA
altered the recovery of MX mutagenicity in each fraction
suggested that the MX was still restricted to the first
fraction but recovery was not large enough to draw a
definitive conclusion (Results not shown).
R. Kanniganti (1990) was able to determine by GC/MS
the presence of MX in the reaction sample and fractions 1 &
2 (Table 14).  From the table, approximately 33% of the
activity in the reaction mix is due to MX.  MX accounts for
between 32-43% of the mutagenic activity in Fl and for 26-
30% in F2.
Further GC/MS work tentively identified several
compounds.  The only compounds standard confirmed are
dichloroacetic and trichloroacetic acid.  Previous work
(Waskell, 1978) has shown these compounds to be nonmutagenic
in the Ames assay.
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TABLE 2:   MUTAGENICITY OP BY-PRODUCTS ISOLATED BY
RESIN ADSORPTION
CHLORINE
(itig/L AS
DOSE :
CI2)
44 26 42 43
Resin EH Revertants/Liter
XAD-8 8.0
2.0
NA
T
NA
7680 5380 7064
BLANK 8.0
2.0
1480 NA
NA NA 3929
XAD-4 8.0
1.0
NA
NA
NA
T NA NA
BLANK 8.0
1.0
NA NA
NA NA
T = Toxic
NA = No Activity
Blank = Equal quantity of FA with no chloramination
Four separate chloramination reactions were carried out at a
1:40 C1:C dose ratio.
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TABLE 31  EFFECT OF NHjCl DOSE ON THE MUTAGENIC ACTIVITY OF
PRODUCTS
SET RATIO NH2C1 FA REV/L  REV/L REV/
C1:C (mg/L as Clj) (rag/L as C) (Mean+S.D.) mg FA
1 1:40 40.00 268.80 NA 3964 + 0.00
2 1:40 50.00 333.11 5672 3443 17.03
3 1:40 60.00 399.61 6220 n=3 15.57
4 1:20 80.00 271.20 10688 39.41
5 1:10 160.00 270.00 15131 18639 + 56.04
6 1:10 170.00 283.12 16946 5497 59.85
7 1:10 180.00 299.79 13840 n=5 46.17
8 1:10 200.00 333.04 27680 83.11
9 1:10 225.00 374.79 19600 52.30
10 1 :5 250.00 207.79 10066 20572 + 48.44
11 1 :5 250.00 207.79 11739 6432 56.49
12a 1 5 269.80 224.63 18225 n=24 81.13
12b 1' 5 269.80 224.63 20388 90.76
12c 1..5 269.80 224.63 26880 119.66
13 1 !5 269.80 224.63 17216 76.64
14a 1 :5 300.00 253.80 20720 81.64
14b 1 :5 300.00 253.80 28288 111.46
14c 1 :5 300.00 253.80 28205 111.13
15a 1 :5 300.00 253.80 20050 79.00
15b 1 5 300.00 253.80 14902 58.72
16a 1. 5 320.00 266.47 21280 79.86
16b 1, 5 320.00 266.47 21303 79.95
17a 1. 5 320.00 266.47 11794 44.26
17b 1 >5 320.00 266.47 13952 52.36
18a 1 :5 325.18 274.80 24704 89.90
18b 1 :5 325.18 274.80 22839 83.11
19a 1 5 325.18 274.80 26992 98.22
19b 1 .5 325.18 274.80 20288 73.83
20a 1 :5 350.00 291.49 22110 75.85
20b 1 :5 350.00 291.49 21561 73.97
21 1 :5 360.00 299.79 9257 30.88
22 1 :5 J60.00 299.79 34377 114.67
23 1 !5 445.00 370.59 27600 74.48
24 1:2 750.00 249.73 33040 30650 + 132.30
25 1:2 800.00 270.48 28260 3380 104.48
26 1 :2 1160.00 386.41 T n=2
All samples labeled a, b, c are aliquots from the same
reaction vessel.
T = Toxic
NA = No activity
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TABLE 4:  RECOVERY OF TOTAL ORGANIC CARBON (TOC) OVER A
RANGE OF CI :C RATIOS
CL:C INITIAL FINAL TOC %TOC TOC in %TOC RECOV
RATIO CARBON in sample" in Rxn EXTRACT' in EXTRACTS
CONC^ Mix
(ppm) (ppm)
1:40 202.80 196.25 96.77 17.91 9.12
1:20 202.80 168.74 83.21 18.96 11.24
1:10 202.80 142.75 70.39 13.68 9.58
1:5 202.80 125.15 61.71 13.62 10.88
l;2 202.80 116.45 57.42 12.70 10.91
a = Carbon concentration calculated from initial FA
concention.
b = TOC present in reaction mix prior to extraction.
c = TOC present in sample after liquid-liquid extraction.
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TABLE 5:  RECOVERY OF TOTAL ORGANIC HALIDE (TOX) OVER A
RANGE OF C1:C RATIOS
CI:C     DOSE       CORRECTED
RATIO    NHjCl      REACTION
TOX/L^
(mg/L as Clj) (mg/L as C1-)
%CL2   CORRECTED %EXTRACT'=
INCORP. EXTRACT   RECOVERY
TOX/L^
(mg/L as C1-)
1:40 30.00 0.49 1.63 0.06 12.24
1:20 57.00 1.12 1.97 0.28 25.00
1:10 106.40 2.57 2.42 0.67 26.07
1:5 211.80 5.68 2.68 1.53 26.94
1:2 571.40 14.53 2.54 3.45 23.74
a = Corrected for blank values of 0.17 for the reaction mix
and 0.10 for the extraction blank.  Blanks consist of 202.80
mg of FA dissolved in 500ml of water with no chloramination
procedure.
b = TOX in reaction mix/NH2Cl dose x 100
c = TOX in extract/TOX in reaction mix x 100
n = 1
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FIG 7:   COMPARISON OF MUTAGENIC ACTIVITY OF
GHLORAMINATION BY-PRODUCTS IN
STRAINS TA100 AND TA98
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TABLE 6:  COMPARISON OP MUTAGENIC ACTIVITY OP CHLORAMINATION
PRODUCTS IN STRAINS TAIOO 2^D TA98
SET
I Table 3)
REV/L %DIF
(Froit TAIOO TA98
21 9257 NA ^,_
BLANK NA 2263
22 34377 7794 ——
BLANK NA 2263
18b 22839 7442 67.4
BLANK NA NA
19b 20288 6272 69.1
BLANK NA NA
MEAN REV/L  : 21564 6857 68.3
± STE>. DEV. ± 1804 ± 827 ±1.2
Each set represents aliquot taken from different reaction
mixture.
NA = No Activity
Blank = Ether extraction of concentration of FA equal to
reaction mixture without addition of NH2C1.
Due to problems with blanks in sets 21 and 22 these values
were not used in computing the overall mean.
These sets are listed in chronological order rather than by
the NH2C1 concentration as done in Table 3.
All samples were chloraminated at C1:C ratio of 1:5.
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FIG 8:   COMPARISON OF MUTAGENIC ACTIVITY OF
CHLORAMINATION BY-PRODUCTS IN TA100
WITH AND WITHOUT METABOLIC ACTIVATION
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TABLE 7:  EFFECT OF S9 ON MUTAGENIC ACTIVITY OF
CHLORAMINATION PRODUCTS
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SET REV/L % DECREASE
(From Table 3) -S9 +S9
12a 18225 8608 52.8
12b 20388 15264 25.1
12c 26880 14032 47.8
13 17216 11040 35.9
14C 28205 21136 25.1
15b 14902 10688 28.3
16b 21303 15840 25.6
17b 13952 4640 66.7
18a 24704 17634 28.6
19a 26992 24192 10.4
MEANS       : 21277 14307 34.6
± STD. DEV. ± 5214 + 5854 ±16.5
All sets represent the same numbered aliquots from Table 3
run simultaneously with the exogenous metabolizing system,
S9.
All sample were chloraminated at a C1:C ratio of 1:5.
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FIG 9:   COMPARISON OF MUTAGENIC ACTIVITY OF CHLORAMINATION
BY-PRODUCTS IN STRAIN TAIOO IN THE PRESENCE ^ ,
OF VARIOUS PROTEINS
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TABLE 8:   EFFECT OF VARIOUS PROTEINS ON THE
MUTAGENICITY OF CHLORAMINATION PRODUCTS
SET 1 REV/L % DECREASE
25.1
6.5
54.1
REV/L
SAMPLE 28205
+S9 21136
+BSA 26377
+Glutathione 12960
SET 2
SAMPLE 14902
+S9 10688
+BSA 13312
+Glutathione 4267
AVERAGE % DECREASE
S9
BSA
GLUTATHIONE
28.3
10.7
71.4
26.7 +/-  2.3
8.6 +/-  3.0
62.8 +/- 12.2
BSA = Bovine Serum Albumin
All proteins were dosed at 0.8 mg/plate
f^K
BI_«|NIK      <=k^40    CHLOR^MIhJ^TIOlNi      F^R«OT I Olvl^T I OIM
*
Column:  C-18 Reverse Phase DDS
Detector:  UV, 254nm
Flow Rate:  Iml/min
Mean Mutagenic Value of  Product Injected:  £486 rev/500ui
lOO* CH3CN
50% Phosphate buffer (ph=5.Oi
50% CH3CN
90?c Phosphate buffinr (pH»3.0>
10* CH3CN
30 £0 90 120 150 180
Time
50* Phosphate buffor   (pH=3.0>
50* CH3CN
90* Phosphate buffer (pH»3.0)
10* CH3CN
lOO* CH3CN
00
180 150 ISO
Time
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TABLE 91   RECOVERY OF MUTAGENICITY FROM HPLC FRACTIONATION
SET 1        INJECTED REVERTANTS:  2379
FRACTION
UNBUFFERED
SAMPLE WHOLE
Fl
F2
F3
F1+F2+F3
BUFFERED
SAMPLE WHOLE
Fl
F2
F3
RECOVERED
MUTAGENICITY
1540
1012
464
NA
1476
956
F1+F2+F3
1872
584
NA
% OF MUTAGENICITY
RECOVERED
64.7
2456
42.5
19.5
62.0
40.2
78.7
24.5
103.2
SET 2
UNBUFFERED
SAMPLE WHOLE
Fl
F2
F3
INJECTED REVERTANTS:  2462
F1+F2+F3
BUFFERED
SAMPLE -WHOLE
Fl
F2
F3
1456
424
396
NA
F1+F2+F3
820
2148
1072
596
NA
59.1
17.2
16.1
1668
33.3
87.2
43.5
24.2
67.7
Buffered = lO'^M phosphate buffer at pH=3.0 was used instead
of distilled deionized water for elution.
NA = No Activity
nc.  11: RECOVERY OE MUTAGENIC ACTIVITY
IN HPLC ERACTIONS
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TABLE  10:  ADDITIVE PROPERTIES OP FRACTIONS
SET 1 INJECTED REVERTANTS:  2300
FRACTION RECOVERED REV
SAMPLE WHOLE 1280
Fl 908
F2 340
F3 NA
F1+F2+F3 1885
Fl, F2, F3 1010
See above
RECOVERY
55.7
39.5
14.8
F1+F2+F3 1248 54.3
Fl, F2, F3 1552 67.5
collected separately
and recombined
SET 2        INJECTED REVERTANTS:  2760
SAMPLE WHOLE 1355 49.1
Fl 1280
F2 605
3 NA
46 .4
21 9
"" ͣ ͣ
. 68 3
36. 6
AVERAGE      INJECTED REVERTANTS:  2530
SAMPLE WHOLE 1318 ±53 52.4 ±  4.7
Fl 1094 ± 263 43.0+  4.9
F2    ' 473 ± 187 18.4 ±  5.0
3 NA
F1+F2+F3 1719 ± 235 61.3 ±  9.9
Fl, F2, F3 1281 ± 383 52.1 ± 21.8
All fractionations were done with lO'^M phosphate buffer at
pH=3.0.
NA = No Activity
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TABLE  11: RECOVERY OF TOX AND TOC IN FRACTIONS
TOX % TOX TOC % TOC
IN SAMPLE RECOVERY IN SAMPLE RECOVERY
(mg/L as CI2) (ppm)
1:5" 2.02 — 19.86 —
Fl 0.53 26.24 5.01 25.23
F2 0.57 28.22 6.94 34.94
F3 0.30 14.85 2.40 12.08
TOTAL 1.40 69.31 14.35 72.25
(F1+F2+F3)
a = TOX and TOC values for the reaction extract prior to
fractionation.
Values are mean values from duplicate TOX determinations.
FIG 12:   ACTIVITY OF MX IN TAIOO IN THE
PRESENCE OF VARIOUS PROTEINS
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TABLE  12:  EFFECT OF VARIOUS PROTEINS ON THE
__________________________MUTAGENICITY OF MX________________
SET 1 REV/ng % DECREASEREV/ng
MX 21.4
+39 7.8
+BSA 18.5
+Glutathione 3.9
63.7
13.4
82.0
SET 2
62.7
16.0
82.4
63.2 ± 0.7
14.7 + 1.8
82.2 + 0.3
MX 30.4
+S9 11.3
+BSA 25.6
+Glutathione 5.4
AVERAGE % DECREASE
S9
BSA
GLUTATHIONE
BSA = Bovine Serum Albumin
MX dose = 0.15 ng/ul
Protein dose =0.8 mg/plate
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TABLE  13: DISTRIBUTION OP MUTAGENIC ACTIVITY DUE TO MX
OVER HPLC FRACTIONATION SCHEME
SET 1
FRACTION
Fl
F2
F3
INJECTED REVERTANTS:  6985
RECOVERED REVS
1792
NA
NA
% RECOVERY
25.8
SET 2
FRACTION
Fl
F2
F3
INJECTED REVERTANTS:   7450
RECOVERED REVS       % RECOVERY
4616 62.0
NA
NA
MX fractionation was carried out under the same HPLC regimen
as the chloramine sample fractionation.
NA = No Activity
ss^st^
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Tl^LE  14: QUANTITATION OP MX IN EXTRACT FROM REACTION OP
MONOCHLORAMINB AND PULVIC ACID
SAMPLE MX CONC. ACTIVITY % CONTRIBUTION
IN SAMPLE^ DUE TO MX OF MX TO
(ng/L) (rev/L) TOTAL activity"
EXTRACT 240 6605 31.2
264 7265 34.3
252 6935 32.8
HPLC 124 3412 32.5
FRAC. 1 164 4513 43.0
HPLC 48 1321 29.1
FRAC. 2 44 1211 26.7
HPLC 0 0 0
FRAC. 3 0 0 0
a = Corrected for aliquot injected into the HPLC
b = The percentage of the total activity in the extract or
the fractions that could possibly be accounted for by MX.
Total activities :
Extract
Fl
F2
F3
21835 rev/L (mean of 20a,b from Table 3)
10502 rev/L (calculated from table 10)
4541 rev/L (calculated from table 10)
No Activity
v.:  DISCUSSION, CONCLUSIONS, AND RECOMMENDATIONS
V. 1.:  Discussion of Results
V. 1. (a):  Recovery of Mutagenic By-products
Kronberg et al (1986) found that liquid-liquid
extractions and resin extractions were both acceptable
methods for recovery of mutagenic activity of disinfection
by-products.  In this study diethyl ether extractions proved
to be the most effective method of recovering mutagenic by¬
products.  Resin extractions gave comparable results but did
not allow for flexibility in the Cl:C molar ratios due to
the failure of the resins to completely separate the
monochloramine.  This necessitated work be done at the
chlorine demand levels of the fulvic acid.  An explanation
for this may be the increased polarity of NHjCl over Clj
resulting in a greater affinity of NHjCl for the resin
therefore making separation of the NHjCl from the resin
during extraction more difficult.
The work done with the resins and extracts also
indicated that extraction pH was important in the recovery
of mutagens.  Mutagenic activity was found in samples that
had been acidified to pH 2.0 but not in those remaining at
pH 8.0. Meier (1988) found this pH dependence in the
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recovery of mutagenic activity from chlorinated samples as
did Kronberg et ai (1985).  This indicated that the
mutagenic compounds formed were acidic and polar in nature
and exhibited the most mutagenic activity in their
protonated form.
Lyophilization of the reaction products resulted in
the recovery of no mutagenic activity.  This was surprising
because Meier et al (1983) found that after lyophilization
of chlorinated humic acids, 80-90% of the mutagenic activity
present prior to lyophilization remained.  A possible
explanation for this discrepancy may be the difference in
molar ratios used.  This study incorporated a 1:40 C1:C
ratio whereas Meier et al (1983) worked with molar ratios of
1:1.  The sheer bulk of the carbon present in this study may
have masked the mutagens present.  Another explanation may
be some of the material may have volatilized during
lyophilization.
V. 1. (b):  Relationship of NH2C1 Dose and Mutagenicity
There seems to be relationship between the NHjCl dose
and the mutagenic activity.  This has been found in other
studies dealing with chloramination (Miller et al, 1986) and
chlorination (Backlund et al, 1985; Kronberg et al, 1985;
and Meier et al, 1983).  Backlund e£ al (1988) found
activity in the range of 1110 rev/L at NHjCl doses of lOmg/L
and a C1:C ratio of 1:2.  This is fairly consistent with
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this study's discovery of approximately 20,572 ± 6432 rev/L
at NHjCl doses of 250-445 mg/L and C1:C ratios of 1:5.
Miller et al (1986) found that chloramination produced 45%
less mutagenicity than chlorination.  Our study, in
comparison with a chlorination study by Kronberg et al
(1986) with similar reaction conditions (C1:C = 1:6, RXN
time = lOOhrs., Extraction pH = 2.0), produced 19% of the
mutagenic activity formed in chlorination.
An important aspect of the NHjCl and mutagenicity
relationship is the biphasic nature of Figs. 5, and 6.  Fig.
5 suggests that the mutagenic activity reaches a plateau
between the C1:C ratios of 1:10 and 1:5. A normal water
treatment C1:C dose ratio of 2-3:1 would be expected to
produce mutagenicity in these quantities.  Fig. 6 shows that
the maximum percentage of NHjCl incorporated also plateau in
this region suggesting the total mutagenic activity is
related to the TOX formed.  The relation between the TOX and
genotoxic activity has been reported previously (Meier,
1988).  However, this does not necessarily indicate a causal
relationship.
From Table 5, it was seen that the %Cl2 incorporation
ranges from 1.63 at a NHjCl dose of 30.00 mg/L to 2.68 at
211.80 mg/L.  These values are well within the 2%
incorporation rate Fleischacker and Randtke (1983) found.
Also our % extract recovery values ranging from 12.24 at the
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30 mg/L dose to 26.94 at the 571.40 dose correlated well
with the 20% recovery reported by Jensen (1983).
V. 1. (c):  Strain Characterization
In the present study TAIOO and TA98 were used to
assay the mutagenicity present.  TAIOO proved to be 3 times
more sensitive to the mutagenic compounds present indicating
that these compounds were preferentially inducing base-pair
substitutions as opposed to frame-shift mutations.  These
findings are supported by the work of Loper (1980) and
Nestman et al (1979).  Other disinfection studies have found
TAIOO to show the most mutagenic activity (Horth et al.
1987; Meier et al, 1985).  Hemming et al (1986) also found
TA98 to show more pronounced effects of toxicity in
chlorinated waters.
However, Schenk et al (1990b) found monochloramine
extracts to be more active in TA98.  This may be a
reflection of the increased toxicity at higher dose levels
noted in this research and the Hemming et al (1986) study.
V. 1. (d):  Presence of Exogenous Metabolizing Systems
In this study, it was found that the addition of
mammalian metabolizing systems and proteins had a
significant effect on the mutagenic activity present in both
chloramine extracts and pure MX.  The inactivation by S9 of
mutagens in chlorinated drinking water extracts has been
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previously noted (Backlund et al, 1985; Holmbom et al, 1984;
Kronberg et al, 1985; Meier et al, 1983).  The inactivation
by glutathione has been attributed to the strong
electrophilic nature of the mutagens formed, expressly that
of the strong mutagen, MX (Ishiguro et al., 1987; Meier et
^, 1987a) .
In this study the addition of BSA also contributed to
a small but statistically significant decrease in the
mutagenicity present indicating some nonspecific protein
binding was occurring.  Lampelo et al (1989) also reported a
small decrease in activity of MX in the presence of albumin.
However Meier et al (1983) reported that the addition of BSA
to the standard S9 mix had no effect on the mutagenicity
present in chlorinated waters.
It was estimated that no more than one-half of the
activity present in the reaction extract could be attributed
to MX.  This was determined by comparing the reduction in
activity of MX in each of the proteins the reduction in
mutagenic activity due to the proteins in the chloramine
extract.   GC/MS work later indicated one-third of the
activity could be attributable to MX.  Backlund et al.
(1988) determined the contribution of MX to the overall
mutagenicity of chloramination by-products to be 24%.
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V. 1. (e):  HPLC Fractions
From the HPLC fractionations in this study the
recovery is only in the 50-60% range.  This indicates that
many mutagens may have adsorbed to the column and failed to
elute.  TOX and TOC recovery was slightly higher (60-70%) in
a single determination.  Separations done to determine if
synergistic or antagonistic effects were present showed that
neither effect was in fact operating, which has been seen in
previous chlorination experiments (Fielding and Horth, 1986;
Hemming et al, 1986; Meier et al, 1986).  Approximately 40%
of the injected mutagenicity was found in fraction 1.  This
suggests a polar nature to the mutagens.  This also
reinforces the notion that extraction at low pH is essential
to mutagenicity recovery.  Previous research (Holmbom et al.
1984; Kronberg, 1987; Kronberg et al, 1985) has also
indicated that a greater number of the mutagens are present
in the polar fractions. Meier et al (1986) found 43% of the
total activity produced during chlorination was recoverable
in the strong acid fraction.
Separation of MX was carried out in the same HPLC
regimen to determine into which fractions it would elute.
All of the recovered activity was found in fraction 1 as
would be expected because of the polar nature of MX (Holmbom
et al. 1984).  In the first experiment done to recover the
MX in fractions, there was most likely some experimental
error contributing to the poor recovery.  The tendency for
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the MX to elute in the first fraction would account for the
fact that although containing less TOX than fraction 2,
fraction 1 contains twice the mutagenic activity.  GC/MS
work later confirmed that MX was present in fraction 1 at
levels 3-4x that found in fraction 2, even though HPLC work
suggested MX would not be found in fraction 2.  Once again
MX accounted for approximately 30-40% of the total activity
in each fraction.
V. 1. (e) :  Identification of Compounds
Several compounds have been tentively identified.
J'heir ability to produce peaks and spectra indicates they
are fairly abundant in the extract.  The quantification and
identification of the compounds would need to be far more
extensive prior to delving into a more thorough discussion
of their mutagenic properties.  However, two of the listed
compounds have been standard confirmed, dichloro- and
trichloroacetic acid, and they are known to be non-mutagenic
in the Ames assay (Waskell, 1978).  Based on previous
laboratory work (Fielding and Horth, 1986; Meier et al,
1985), arid their tentative structures, upon positive
identification, the identified compounds will very possibly
contribute little to the overall mutagenicity of the sample.
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V. 2. t  Conclusions
(A).  Mutagenic activity resembles that displayed by
MX, however there are probably more mutagens
present that are neither as electophilic nor as
readily inactivated by cytochrome P-450.
(B).  Monochloramination produces direct-acting
mutagens that are more likely to induce
base-pair substitutions than frame-shift
mutations.
(C).  Glutathione greatly reduced the amount of
mutagenic activity suggesting an electrophilic
nature to the major mutagens.  BSA induced a
small but significant decrease in activity.
(D).  Liquid-Liquid extraction may be a more suitable
method of concentration and extraction than
resin adsorption because it separates the
monochloramine residual and does not create
mutagenic artifacts.
(E).  Extraction at acidic pH is critical for
recovery of mutagenic by-products.
(F).  Production of mutagenic by-products is a
function of the NHgCl dose.  It tends to be
linear until high doses and then plateaus.
(G).  Low extraction recoveries of TOX and TOC
indicate that only a small percentage of the
products formed are seen.
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(H).  TOX may be related to the mutagenicity formed.
(I).  Recovery of mutagens from HPLC fractionation
indicated that activity may be due to acidic,
polar compounds.
(J).  GC/MS work indicates that MX may account for
one-third of the total activity present in the
reaction extract.
Recently, a major effort has been made to raise the
awareness of the potential dangers inherent in water
chlorination.  However, prior to major upheavals in the
treatment process, it is necessary to evaluate prospective
alternative disinfectants in regards to their possible human
health effects.  Regretably, the research in these areas
lags far behind that in chlorination by-products.  It was
the aim of this study to further explore the genotoxic
effects of chloramination and compare these results with
previous work done on chlorination.  It is seen that less
mutagenic activity is formed by chloramination, but
identification of the mutagens is still lacking. Without
some knowledge of the identity of the mutagens, it is still
difficult to reconanend one treatment over another.
Therefore, included are some recommendations of future
research needed to further identify and characterize the
mutagens.
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V. 3. Recommendations for Future Research
(a).  Isolate and identify the non-MX mutagenicity
and compare with structures identified in
chlorination extracts to determine the
similarity of products formed.
(b).  Assay the extract with test strain TA102,
especially at higher NH2C1 doses, to determine
if any oxidative damage to the genome could
occur.
(c).  Further separate HPLC fractions 1 and 2, and
characterize their mutagenic activity in
regards to tester strains and exogenous
metabolizing systems.
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